Revenue
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Nymox Pharmaceutical Corp (NYMXF)
Price$0.0002Cached quote
Net income
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Free cash flow
2016
2018
2019
2020
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Financial statements
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $5,000 | $116,000 | $299,000 | $224,000 | $284,000 | $2.8M |
| Gross profit | — | $0 | $0 | $0 | $1,000 | $58,000 | $161,000 | $75,000 | $111,000 | $2.6M |
| Gross margin | — | — | — | — | 20.00% | 50.00% | 53.85% | 33.48% | 39.08% | 94.20% |
| Research & development | $3.3M | $4.0M | $3.8M | $6.7M | $8.1M | $7.4M | $6.7M | $7.9M | $6.8M | $8.7M |
| Operating expenses | $4.3M | $8.3M | $6.7M | $12.5M | $11.7M | $13.4M | $10.8M | $13.3M | $13.0M | $20.3M |
| Operating income | −$4.3M | −$8.3M | −$6.7M | −$12.5M | −$11.7M | −$13.3M | −$10.6M | −$13.2M | −$12.9M | −$17.7M |
| Operating margin | — | — | — | — | −234,400.00% | −11,487.07% | −3,558.86% | −5,908.48% | −4,531.34% | −639.62% |
| EBITDA | −$4.3M | −$8.3M | −$6.6M | −$12.5M | −$11.7M | −$13.3M | −$10.6M | −$13.2M | −$12.9M | −$11.7M |
| EBITDA margin | — | — | — | — | −234,220.00% | −11,479.31% | −3,557.86% | −5,907.59% | −4,529.93% | −422.24% |
| Net income | −$4.5M | −$8.8M | −$6.6M | −$12.5M | −$11.7M | −$13.2M | −$10.6M | −$13.4M | −$13.1M | −$17.9M |
| Net profit margin | — | — | — | — | −234,760.00% | −11,346.55% | −3,543.14% | −5,995.09% | −4,616.20% | −648.10% |
| Basic EPSper basic share | -$0.05 | -$0.10 | -$0.07 | -$0.15 | -$0.16 | -$0.19 | -$0.18 | -$0.26 | -$0.28 | -$0.48 |
| Diluted EPSper diluted share | -$0.05 | -$0.10 | -$0.07 | -$0.15 | -$0.16 | -$0.19 | -$0.18 | -$0.26 | -$0.28 | -$0.48 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
First Citizens Financial Corp | 35.1K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data